SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216394 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Faith N Burnett und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Medicine, Mercer University, Savannah, GA 31404, USA. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association.
Abstract (Originalsprache)
Diabetics are more vulnerable to SARS-CoV-2 neurological manifestations. The molecular mechanisms of SARS-CoV-2-induced cerebrovascular dysfunction in diabetes are unclear. We hypothesize that SARS-CoV-2 exacerbates diabetes-induced cerebrovascular oxidative stress and inflammation via activation of the destructive arm of the renin–angiotensin-aldosterone system (RAAS) and Toll-like receptor (TLR) signaling. SARS-CoV-2 spike protein was injected in humanized ACE2 transgenic knock-in mice. Cognitive functions, cerebral blood flow, cerebrovascular architecture, RAAS, and TLR signaling were used to determine the effect of SARS-CoV-2 spike protein in diabetes. Studies were mirrored in vitro using human brain microvascular endothelial cells treated with high glucose-conditioned media to mimic diabetic conditions. Spike protein exacerbated diabetes-induced cerebrovascular oxidative stress, inflammation, and endothelial cell death resulting in an increase in vascular rarefaction and diminished cerebral blood flow. SARS-CoV-2 spike protein worsened cognitive dysfunction in diabetes compared to control mice. Spike protein enhanced the destructive RAAS arm at the expense of the RAAS protective arm. In parallel, spike protein significantly exacerbated TLR signaling in diabetes, aggravating inflammation and cellular apoptosis vicious circle. Our study illustrated that SAR-CoV-2 spike protein intensified RAAS and TLR signaling in diabetes, increasing cerebrovascular damage and cognitive dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Medicine, Mercer University, Savannah, GA 31404, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, South University, Savannah, GA 31406, USA.
ORCID-Profile: Mohammed Abdelsaid
Förderung
- American Heart Association
Zitieren
APA
Burnett, F. N., Coucha, M., Bolduc, D. R., Hermanns, V. C., Heath, S. P., Abdelghani, M., Macias-Moriarity, L. Z., & Abdelsaid, M. (2023). SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216394
Vancouver
Burnett FN, Coucha M, Bolduc DR, Hermanns VC, Heath SP, Abdelghani M, et al. SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216394
BibTeX
@article{Burnett2023,
author = {Burnett, Faith N and Coucha, Maha and Bolduc, Deanna R and Hermanns, Veronica C and Heath, Stan P and Abdelghani, Maryam and Macias-Moriarity, Lilia Z and Abdelsaid, Mohammed},
title = {SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216394}
}
EUVIMED